Gray matter alterations in Huntington's disease: A meta‐analysis of VBM neuroimaging studies

Abstract

Increasing neuroimaging studies have attempted to identify biomarkers of Huntington's disease (HD) progression. Here, we conducted voxel‐based meta‐analyses of voxel‐based morphometry (VBM) studies on HD to investigate the evolution of gray matter volume (GMV) alterations and explore the effects of genetic and clinical features on GMV changes. A systematic review was performed to identify the relevant studies. Meta‐analyses of whole‐brain VBM studies were performed to assess the regional GMV changes in all HD mutation carriers, in presymptomatic HD (pre‐HD), and in symptomatic HD (sym‐HD). A quantitative comparison was performed between pre‐HD and sym‐HD. Meta‐regression analyses were used to explore the effects of genetic and clinical features on GMV changes. Twenty‐eight studies were included, comparing a total of 1811 HD mutation carriers [including 1150 pre‐HD and 560 sym‐HD] and 969 healthy controls (HCs). Pre‐HD showed decreased GMV in the bilateral caudate nuclei, putamen, insula, anterior cingulate/paracingulate gyri, middle temporal gyri, and left dorsolateral superior frontal gyrus compared with HCs. Compared with pre‐HD, GMV decrease in sym‐HD extended to the bilateral median cingulate/paracingulate gyri, Rolandic operculum and middle occipital gyri, left amygdala, and superior temporal gyrus. Meta‐regression analyses found that age, mean lengths of CAG repeats, and disease burden were negatively associated with GMV atrophy of the bilateral caudate and right insula in all HD mutation carriers. This meta‐analysis revealed the pattern of GMV changes from pre‐HD to sym‐HD, prompting the understanding of HD progression. The pattern of GMV changes may be biomarkers for disease progression in HD.